[HTML][HTML] Updates and new options in advanced epithelial ovarian cancer treatment
Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research
Alliance. Katherine Kurnit disclosed receiving funds from the GOG Foundation on behalf of
LEAP Therapeutics. Gini Fleming disclosed receiving funds for serving on the advisory
board of GSK, a planned presentation from OncLive, and Corcept.
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research
Alliance. Katherine Kurnit disclosed receiving funds from the GOG Foundation on behalf of
LEAP Therapeutics. Gini Fleming disclosed receiving funds for serving on the advisory
board of GSK, a planned presentation from OncLive, and Corcept.
Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research Alliance. Katherine Kurnit disclosed receiving funds from the GOG Foundation on behalf of LEAP Therapeutics. Gini Fleming disclosed receiving funds for serving on the advisory board of GSK, a planned presentation from OncLive, and Corcept.
Lippincott Williams & Wilkins